{
    "Trade/Device Name(s)": [
        "First Sign Drug of Abuse MDMA Cup Test",
        "First Sign Drug of Abuse MDMA Dip Card Test",
        "First Sign Drug of Abuse EDDP Cup Test",
        "First Sign Drug of Abuse EDDP Dip Card Test",
        "First Sign Drug of Abuse Nortriptyline Cup Test",
        "First Sign Drug of Abuse Nortriptyline Dip Card Test"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K160793",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142800",
        "K140748"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "LAF",
        "LFG"
    ],
    "Summary Letter Date": "June 29, 2016",
    "Summary Letter Received Date": "July 7, 2016",
    "Submission Date": "March 15, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Methadone test system",
        "Methamphetamine Test System",
        "Tricyclic Antidepressant Drugs Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "MDMA",
        "EDDP",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Immunochromatographic lateral flow assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Lateral flow chromatographic immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Kit",
        "Dip Card",
        "Cup",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Drug of Abuse MDMA, EDDP, and Nortriptyline urine lateral flow immunoassay tests in cup and dip card formats for over-the-counter and prescription use.",
    "Indications for Use Summary": "Qualitative, preliminary detection of MDMA, EDDP, or Nortriptyline in human urine for over-the-counter or prescription use; results should be confirmed by a more specific chemical method such as GC/MS.",
    "fda_folder": "Toxicology"
}